State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
83 hedge funds and large institutions have $235M invested in State Street SPDR S&P Pharmaceuticals ETF in 2026 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 20 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13.64% more ownership
Funds ownership: 62.63% → 76.27% (+14%)
8% more funds holding
Funds holding: 77 → 83 (+6)
Holders
83
Holding in Top 10
–
Calls
$2.15M
Puts
$795K
Top Buyers
| 1 | +$40.5M | |
| 2 | +$25.4M | |
| 3 | +$16.5M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$11M |
| 5 |
Morgan Stanley
New York
|
+$8.16M |
Top Sellers
| 1 | -$5.91M | |
| 2 | -$5.01M | |
| 3 | -$3.42M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.67M |
| 5 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
-$1.32M |
